Anti-Monocyte Chemoattractant Protein-1 Gene Therapy Limits Progression and Destabilization of Established Atherosclerosis in Apolipoprotein E

Anti-Monocyte Chemoattractant Protein-1 Gene Therapy Limits Progression and Destabilization of Established Atherosclerosis in Apolipoprotein E–Knockout Mice

Published:2002-11-19 Issue:21 Volume:106 Page:2700-2706
ISSN:0009-7322
Container-title:Circulation
language:en
Short-container-title:Circulation

Author:

Inoue Shujiro¹,Egashira Kensuke¹,Ni Weihua¹,Kitamoto Shiro¹,Usui Makoto¹,Otani Kisho¹,Ishibashi Minako¹,Hiasa Ken-ichi¹,Nishida Ken-ichi¹,Takeshita Akira¹

Affiliation:

1. From the Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan; and New Product Research Laboratories (K.N.), Dai-ichi Pharmaceutical Co, Tokyo, Japan.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Reference28 articles.

1. Atherosclerosis — An Inflammatory Disease

2. Inhibition of CD40 signaling limits evolution of established atherosclerosis in mice

3. Both early and delayed anti-CD40L antibody treatment induces a stable plaque phenotype

4. CD40 signaling in vascular cells: A key role in atherosclerosis?

Cited by 240 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cyclophilin D induces necrotic core formation by mediating mitochondria-associated macrophage death in advanced atherosclerotic lesions;Atherosclerosis;2024-09

2. Therapy Combining Glucagon-Like Peptide-1 Receptor Agonist with Sodium-Glucose Cotransporter 2 Inhibitor Suppresses Atherosclerosis in Diabetic ApoE-Deficient Mice;Experimental and Clinical Endocrinology & Diabetes;2024-04-16

3. Pathogenesis of Atherosclerosis and Coronary Heart Disease: Epidemiology, Diagnostic Biomarkers and Prevention by Nutraceuticals, Functional Foods, and Plant-Derived Therapies;Bentham Briefs in Biomedicine and Pharmacotherapy;2024-03-24

4. Conditional deletion of Ccl2 in smooth muscle cells does not reduce early atherosclerosis in mice;Atherosclerosis Plus;2024-03

5. Mural cell-derived chemokines provide a protective niche to safeguard vascular macrophages and limit chronic inflammation;Immunity;2023-10